Biostatistics

Funding

Computational Models of Neoplasmic Heterogeneities and Lineage Choice

Collaborative Research Centre 1243 "Genetic and Epigenetic Evolution of Hematopoietic Neoplasms", Subproject A17

Principal investigators of the subproject: Christiane Fuchs, Fabian Theis

Funding period: 2016-2019

Acute myeloid leukemia (AML) often results from the myelodysplastic syndrome (MDS). Here, the differentiation hierarchy from hematopoietic stem cells to mature, functional cells is disturbed. AML patients, again, frequently carry a mixture of different cancer cell types, so-called subclones. This is reflected by a mixture of genomic signatures and heterogeneous transcriptome profiles. Applying statistical and dynamical models to data from our clinical and biological collaborators in this CRC, we want to identify altered differentiation hierarchies of MDS subclones and characterize the development of related heterogeneities in AML while the tumor undergoes evolution.

More information: Webpage of the CRC 1243

An Integrated Systems Approach for Incompletely Penetrant Onco-Phenotypes

National Institutes of Health

Principal investigator: Kevin Janes

Co-Investigators: Christiane Fuchs, Fabian Theis, Kristen Atkins, Jennifer Harvey

Funding period: 2017-2022

HER2+ breast cancer is an aggressive subtype of breast cancer with targeted drugs available, but not all of these patients respond to HER2-directed therapies. Our project will develop an experimental approach to determine why cancer cells do not respond uniformly when their molecular pathways are perturbed by stimuli or drugs. The results from this work could one day lead to combination therapies that increase the percentage of cancer patients who respond to anti-cancer agents.

More information: Project webpage

Stochastic and Statistical Modeling of Biomarkers in Breast Cancer Disease Progression

Federal Ministry of Education and Research

Principal investigators: Christiane Fuchs, Hamid El Maroufy

Funding period: 2017-2020

Breast cancer is one of the most common cancers in women worldwide. An effective assessment of multiple variants of therapies and treatments requires information about the progression of the disease from one stage to another. The exact diesease stage is often unobserved due to the invasive nature of measurements. One hence aims to well understand the relationship between tumor markers and disease progression. In this project, we develop and apply stochastic Hidden Markov Models and according inference techniques to characterize breast cancer disease progression with the help of biomarkers. The strategic goal of this collaborative project is to improve the efficacy of treatments for women with breast cancer and to reduce their costs.

Making Inference of Biological Processes more Reliable using Stochastic Models

Postdoc Fellowship Programme of the Helmholtz Zentrum München

Grant holder: Christiane Fuchs

Funding period: 2014-2017

The molecular biology of life seems inaccessibly complex. It is subject to random variation and not exactly predictable. Still, mathematical models and statistical inference pave the way towards the understanding of biological mechanisms. In contrast to deterministic models, stochastic processes capture the randomness of natural phenomena and result in more reliable predictions of cellular dynamics. In this project, we develop and apply stochastic models and statistical inference techniques to dynamic biological processes.

More information: Webpage of the Postdoctoral Fellowship Program

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.